 Robert Lyle
Concepts (109)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ductus Arteriosus, Patent | 2 | 2019 | 37 | 0.330 |
Why?
| | DNA | 1 | 2010 | 581 | 0.280 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2018 | 117 | 0.280 |
Why?
| | Asthma | 1 | 2010 | 293 | 0.280 |
Why?
| | Infant, Premature | 4 | 2019 | 335 | 0.230 |
Why?
| | Medicaid | 2 | 2018 | 267 | 0.210 |
Why?
| | Disabled Children | 2 | 2013 | 73 | 0.200 |
Why?
| | Infant, Newborn | 7 | 2019 | 2907 | 0.180 |
Why?
| | Hospitalization | 2 | 2017 | 705 | 0.180 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2019 | 10 | 0.170 |
Why?
| | Health Care Costs | 2 | 2018 | 171 | 0.170 |
Why?
| | Chronic Disease | 3 | 2011 | 614 | 0.170 |
Why?
| | Infant, Low Birth Weight | 1 | 2018 | 75 | 0.160 |
Why?
| | Child, Preschool | 7 | 2018 | 4147 | 0.160 |
Why?
| | Continuity of Patient Care | 1 | 2018 | 64 | 0.150 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2016 | 20 | 0.140 |
Why?
| | Clinical Protocols | 1 | 2017 | 122 | 0.140 |
Why?
| | Hypoglycemia | 1 | 2016 | 61 | 0.140 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 91 | 0.140 |
Why?
| | DNA Copy Number Variations | 2 | 2016 | 114 | 0.140 |
Why?
| | Developmental Disabilities | 1 | 2016 | 127 | 0.130 |
Why?
| | Child | 8 | 2018 | 7341 | 0.130 |
Why?
| | Hospitals, Pediatric | 3 | 2013 | 272 | 0.120 |
Why?
| | Comprehensive Health Care | 1 | 2013 | 9 | 0.120 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 539 | 0.120 |
Why?
| | Infant | 6 | 2018 | 3817 | 0.110 |
Why?
| | Blood Cells | 1 | 2012 | 58 | 0.100 |
Why?
| | Child, Exceptional | 1 | 2011 | 6 | 0.100 |
Why?
| | Genome, Human | 1 | 2012 | 131 | 0.100 |
Why?
| | Cost Savings | 1 | 2011 | 67 | 0.100 |
Why?
| | Parents | 1 | 2013 | 344 | 0.090 |
Why?
| | Fetal Blood | 1 | 2010 | 67 | 0.090 |
Why?
| | Follow-Up Studies | 2 | 2018 | 2387 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2010 | 151 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2010 | 136 | 0.090 |
Why?
| | Longitudinal Studies | 3 | 2018 | 746 | 0.090 |
Why?
| | Ambulatory Care | 1 | 2011 | 230 | 0.090 |
Why?
| | Patient Care Team | 1 | 2011 | 273 | 0.080 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2009 | 44 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2013 | 543 | 0.080 |
Why?
| | Genotype | 1 | 2010 | 599 | 0.080 |
Why?
| | Time Factors | 2 | 2018 | 3213 | 0.080 |
Why?
| | Humans | 13 | 2022 | 54284 | 0.080 |
Why?
| | Child Health Services | 1 | 2009 | 98 | 0.080 |
Why?
| | Home Care Services | 1 | 2009 | 79 | 0.080 |
Why?
| | Female | 8 | 2018 | 28441 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 552 | 0.070 |
Why?
| | Male | 7 | 2018 | 27334 | 0.070 |
Why?
| | DNA Methylation | 1 | 2010 | 574 | 0.070 |
Why?
| | Cohort Studies | 3 | 2018 | 1543 | 0.070 |
Why?
| | Patient Discharge | 2 | 2018 | 353 | 0.060 |
Why?
| | Prospective Studies | 1 | 2010 | 2604 | 0.060 |
Why?
| | Embryonic Stem Cells | 1 | 2022 | 17 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2022 | 720 | 0.050 |
Why?
| | Age Factors | 2 | 2018 | 1198 | 0.050 |
Why?
| | Peptide Hydrolases | 1 | 2002 | 67 | 0.050 |
Why?
| | Acetylcysteine | 1 | 2002 | 118 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2002 | 116 | 0.050 |
Why?
| | Adolescent | 3 | 2018 | 6897 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2002 | 131 | 0.050 |
Why?
| | Adipocytes | 1 | 2002 | 129 | 0.050 |
Why?
| | Arkansas | 3 | 2013 | 2100 | 0.050 |
Why?
| | Cell Survival | 1 | 2022 | 657 | 0.050 |
Why?
| | Time | 1 | 2018 | 36 | 0.040 |
Why?
| | Indomethacin | 1 | 2018 | 40 | 0.040 |
Why?
| | Ibuprofen | 1 | 2018 | 28 | 0.040 |
Why?
| | Neurons | 1 | 2022 | 486 | 0.040 |
Why?
| | Proteins | 1 | 2002 | 376 | 0.040 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2018 | 44 | 0.040 |
Why?
| | Birth Weight | 1 | 2019 | 126 | 0.040 |
Why?
| | United States | 3 | 2018 | 5217 | 0.040 |
Why?
| | Infant, Newborn, Diseases | 1 | 2016 | 64 | 0.030 |
Why?
| | Patient Readmission | 1 | 2018 | 242 | 0.030 |
Why?
| | Incidence | 1 | 2018 | 1082 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 684 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 995 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 206 | 0.030 |
Why?
| | Length of Stay | 1 | 2018 | 683 | 0.030 |
Why?
| | Young Adult | 2 | 2016 | 4318 | 0.030 |
Why?
| | Genomics | 1 | 2016 | 310 | 0.030 |
Why?
| | Blood Glucose | 1 | 2016 | 489 | 0.030 |
Why?
| | Risk Assessment | 1 | 2018 | 1361 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2013 | 195 | 0.030 |
Why?
| | Twins, Monozygotic | 1 | 2012 | 17 | 0.030 |
Why?
| | Individuality | 1 | 2012 | 31 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2013 | 134 | 0.030 |
Why?
| | Myelodysplastic Syndromes | 1 | 2012 | 79 | 0.030 |
Why?
| | Cerebral Palsy | 1 | 2010 | 43 | 0.020 |
Why?
| | Aged | 2 | 2016 | 10054 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2011 | 291 | 0.020 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2010 | 69 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 643 | 0.020 |
Why?
| | Middle Aged | 2 | 2016 | 13088 | 0.020 |
Why?
| | Adult | 2 | 2016 | 14207 | 0.020 |
Why?
| | Program Evaluation | 1 | 2009 | 374 | 0.020 |
Why?
| | Quality of Life | 1 | 2013 | 922 | 0.020 |
Why?
| | Rural Population | 1 | 2011 | 600 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2018 | 6432 | 0.020 |
Why?
| | Mutation | 1 | 2012 | 1501 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 3431 | 0.010 |
Why?
| | Leupeptins | 1 | 2002 | 8 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2002 | 5 | 0.010 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2002 | 28 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2013 | 5604 | 0.010 |
Why?
| | Calpain | 1 | 2002 | 28 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 692 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2002 | 252 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 1153 | 0.010 |
Why?
| | Animals | 1 | 2002 | 14385 | 0.000 |
Why?
|
|
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
|